Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+Th1 responses against telomerase in cancer patients-Reference-Cited by-同舟云学术

Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+Th1 responses against telomerase in cancer patients

Published:2016-02-18 Issue:5 Volume:5 Page:e1137416
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Laheurte Caroline,Galaine Jeanne,Beziaud Laurent,Dosset Magalie,Kerzerho Jerome,Jacquemard Claire,Gaugler Béatrice,Ferrand Christophe,Dormoy Anne,Aubin François,Jacoulet Pascale,Westeel Virginie,Borg Christophe,Tartour Eric,Godet Yann,Maillère Bernard,Adotévi Olivier

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1137416

Reference49 articles.

1. CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful

2. Th1 epitope selection for clinically effective cancer vaccines

3. Multiple roles for CD4+T cells in anti-tumor immune responses

4. Tumor-Specific CD4+T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity

5. CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of radiochemotherapy on peripheral immune response in glioblastoma;Cancer Immunology, Immunotherapy;2024-05-16

2. First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial;Nature Medicine;2023-08

3. Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma;Cancer Immunology, Immunotherapy;2022-08-21

4. TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition;Frontiers in Immunology;2022-07-22

5. Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in Melanoma;Journal of Investigative Dermatology;2022-02